RPE With ROCK-Mediated Epithelial-Mesenchymal Transition as a Key Contributor of Subretinal Fibrosis in AMD
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.5.33 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Iori Wada and 22 co-authors. Institution: Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Major MEDLINE topics: rho-Associated Kinases, Retinal Pigment Epithelium, Epithelial-Mesenchymal Transition, Macular Degeneration. Cited 1 times so far (Crossref); 61 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Purpose
To investigate the cellular origin and molecular mechanisms underlying subretinal fibrosis (SRF) in neovascular AMD (nAMD), with a focus on the role of RPE and Rho-associated coiled-coil-containing protein kinase (ROCK)-mediated epithelial-mesenchymal transition (EMT).
Methods
Fate-mapping with lineage tracing, laser capture microdissection, microarray and RT-PCR analyses, immunohistochemistry, and functional assays with ROCK inhibitors (Ripasudil, Belumosudil) were used to assess EMT/endothelial-to-mesenchymal transition contributions to SRF and ROCK pathway involvement.
Results
Fate mapping identified RPE and endothelial cells as sources of myofibroblasts. EMT-related gene upregulation and ROCK1/2 expression were observed in SRF lesions. RPE-specific ROCK2 knockout significantly reduced fibrosis and EMT markers. Ripasudil suppressed SRF development and reversed EMT both in vivo and in vitro. ROCK expression was confirmed in human choroidal neovascularization membranes.
Conclusions
RPE-derived myofibroblasts via ROCK2-mediated EMT play a dominant role in SRF formation. ROCK inhibitors, particularly Ripasudil, may serve as effective therapeutic agents against fibrosis in nAMD.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Department of Life Innovation, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
- Department of Microbiology and Immunology, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan.
- John F. Hardesty, MD Department of Ophthalmology & Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, United States.
- Department of Pharmacology, Oita University, Faculty of Medicine, Yufu, Japan.
Cite
APA
Wada, I., Ishikawa, K., Yamaguchi, M., Shimokawa, S., Rui, J., Mori, K., Kaizu, Y., Arima, M., Notomi, S., Murakami, Y., Inagaki, S., Kohro, Y., Tsuda, M., Shibata, K., Terao, R., Terabayashi, T., Ishizaki, T., Yoshida, S., Ishibashi, T., …, & Nakao, S. (2026). RPE With ROCK-Mediated Epithelial-Mesenchymal Transition as a Key Contributor of Subretinal Fibrosis in AMD. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.5.33
Vancouver
Wada I, Ishikawa K, Yamaguchi M, Shimokawa S, Rui J, Mori K, et al. RPE With ROCK-Mediated Epithelial-Mesenchymal Transition as a Key Contributor of Subretinal Fibrosis in AMD. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.5.33
BibTeX
@article{Wada2026,
author = {Wada, Iori and Ishikawa, Keijiro and Yamaguchi, Muneo and Shimokawa, Shotaro and Rui, Ji and Mori, Kenichiro and Kaizu, Yoshihiro and Arima, Mitsuru and Notomi, Shoji and Murakami, Yusuke and Inagaki, Shigenori and Kohro, Yuta and Tsuda, Makoto and Shibata, Kensuke and Terao, Ryo and Terabayashi, Takeshi and Ishizaki, Toshimasa and Yoshida, Shigeo and Ishibashi, Tatsuro and Ishida, Susumu and Apte, Rajendra S and Sonoda, Koh-Hei and Nakao, Shintaro},
title = {RPE With ROCK-Mediated Epithelial-Mesenchymal Transition as a Key Contributor of Subretinal Fibrosis in AMD},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.5.33}
}
EUVIMED